{"id":"cggv:3dcc6918-d7e7-4385-b343-bc8b8678b3a4v1.0","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Limited","contributions":[{"id":"cggv:3dcc6918-d7e7-4385-b343-bc8b8678b3a4_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10035","date":"2020-09-16T19:23:39.841Z","role":"Publisher"},{"id":"cggv:3dcc6918-d7e7-4385-b343-bc8b8678b3a4_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10035","date":"2020-08-12T16:00:00.000Z","role":"Approver"}],"evidence":[{"id":"cggv:3dcc6918-d7e7-4385-b343-bc8b8678b3a4_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:3dcc6918-d7e7-4385-b343-bc8b8678b3a4_ad_other_el","type":"EvidenceLine","evidence":[{"id":"cggv:39aa6286-f8be-43d9-9c19-cd6f20caa858_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:ef46e1ca-6f4b-418d-ab47-e4b087fc1b32","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"MYH7-negative","sex":"Male","variant":{"id":"cggv:39aa6286-f8be-43d9-9c19-cd6f20caa858_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:7509130c-cd20-4044-802c-41d479add4c5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014391.3(ANKRD1):c.827C>T (p.Ala276Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA136853"}},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/19525294","type":"dc:BibliographicResource","dc:abstract":"Dilated cardiomyopathy (DCM) is familial in approximately 30% of cases, and mutations have been identified in several genes. However, in a majority of familial cases, the responsible genes are still to be discovered. The ANKRD1 gene is over-expressed in heart failure in human and animal models. The encoded protein CARP interacts with partners such as myopalladin or titin, previously shown to be involved in DCM. We hypothesized that mutations in ANKRD1 could be responsible for DCM.","dc:creator":"Duboscq-Bidot L","dc:date":"2009","dc:title":"Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525294","rdfs:label":"II.01"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1,"dc:description":"The patient was not screened for other gene variants. Therefore, the score was reduced to 0.1."},{"id":"cggv:5951e386-d70e-4b95-b56c-18b0bdbfb095_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:ba62dd02-6836-452f-a858-5f5b4b48e9a1","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"cggv:5951e386-d70e-4b95-b56c-18b0bdbfb095_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:b4ab9884-0b25-4f9b-b0e2-d6c3b28c2871","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014391.2(ANKRD1):c.169G>C (p.Glu57Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377553495"}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525294"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525294","rdfs:label":"II.01"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1,"dc:description":"The patient was not screened for other gene variants. Therefore the score was reduced to 0.1."},{"id":"cggv:618833c3-e5a0-4a67-a94f-6e367833db4f_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:2277dac0-7fc6-451e-978c-a0766e15a33a","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"cggv:618833c3-e5a0-4a67-a94f-6e367833db4f_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:b99573c7-e75b-46f0-a7ac-84716f3f5b34","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014391.3(ANKRD1):c.368C>T (p.Thr123Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA245339"}},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/25163546","type":"dc:BibliographicResource","dc:abstract":"Numerous genes are known to cause dilated cardiomyopathy (DCM). However, until now technological limitations have hindered elucidation of the contribution of all clinically relevant disease genes to DCM phenotypes in larger cohorts. We now utilized next-generation sequencing to overcome these limitations and screened all DCM disease genes in a large cohort.","dc:creator":"Haas J","dc:date":"2015","dc:title":"Atlas of the clinical genetics of human dilated cardiomyopathy."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25163546","rdfs:label":"ANKRD1: c.368C>T"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1,"dc:description":"No individual patient data, no segregation,no robust evidence for variant pathogenicity. Therefore, the default score of 0.5 is reduced to 0.1 points."},{"id":"cggv:1682f563-4c67-4b81-a287-02b5cd789b64_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:021fbba5-f495-4b8f-b627-ae6a3ec08c78","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"cggv:1682f563-4c67-4b81-a287-02b5cd789b64_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:af94ba7b-a1ec-49a5-bdc3-f01fdd25e06c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014391.2(ANKRD1):c.319G>T (p.Val107Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA136833"}},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/19608030","type":"dc:BibliographicResource","dc:abstract":"We evaluated ankyrin repeat domain 1 (ANKRD1), the gene encoding cardiac ankyrin repeat protein (CARP), as a novel candidate gene for dilated cardiomyopathy (DCM) through mutation analysis of a cohort of familial or idiopathic DCM patients, based on the hypothesis that inherited dysfunction of mechanical stretch-based signaling is present in a subset of DCM patients.","dc:creator":"Moulik M","dc:date":"2009","dc:title":"ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19608030","rdfs:label":"V107L"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1,"dc:description":"ANKRD1-Val107Leu variant showed no differential binding with Talin-1 and FHL2 with respect to the wild-type protein. Functional evidence does not support association with DCM or alteration of DCM causal genes/proteins with this study, but a potential impact can not be excluded. Because the variant alters other genes and impacts gene function, we assigned 0.1 score."},{"id":"cggv:c650eb88-80a3-472c-8a3b-c4a3fc5adc76_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:370cf81b-8293-4901-ad26-1e2bd2a15cc0","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"cggv:c650eb88-80a3-472c-8a3b-c4a3fc5adc76_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:234264f5-62bc-4a0f-ab46-998b68a6b264","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014391.2(ANKRD1):c.596T>G (p.Leu199Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377550793"}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525294"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525294","rdfs:label":"II.03"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1,"dc:description":"The patient was not screened for other gene variants. Therefore the score was reduced to 0.1."},{"id":"cggv:7583ee52-709d-4cb6-abcf-f3431169eb64_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:ad01f811-82ac-4dda-9c24-a1bbd4ad6a92","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"cggv:7583ee52-709d-4cb6-abcf-f3431169eb64_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:aaa7c1b0-b31f-4554-bfd3-7d51e9e6e793","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014391.2(ANKRD1):c.422C>A (p.Ser141Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377552150"}},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/27886618","type":"dc:BibliographicResource","dc:abstract":"Germline genetic variants are an important cause of dilated cardiomyopathy (DCM). However, recent sequencing studies have revealed rare variants in DCM-associated genes also in individuals without known heart disease. In this study, we investigate variant prevalence and genotype-phenotype correlations in Swedish DCM patients, and compare their genetic variants to those detected in reference cohorts.","dc:creator":"Dalin MG","dc:date":"2017","dc:title":"Massive parallel sequencing questions the pathogenic role of missense variants in dilated cardiomyopathy."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/27886618","rdfs:label":"ANKRD1: p.Ser141Ter"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1,"dc:description":"No individual patient data and no clinical evidence provided, therefore, the score was reduced to 0.1."},{"id":"cggv:95f6a460-6ee5-45fa-94c3-ae08f7e3bd0a_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:80d9a9e3-bc33-4c22-b1bc-ca21faad1749","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"cggv:95f6a460-6ee5-45fa-94c3-ae08f7e3bd0a_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:fa17fe28-2e41-4466-b202-061e3004bf18","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014391.2(ANKRD1):c.313C>T (p.Pro105Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA249989"}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25163546"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25163546","rdfs:label":"ANKRD1: 313C>T"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1,"dc:description":"No individual patient data, no segregation,no robust evidence for variant pathogenicity. Therefore, the default score of 0.5 is reduced to 0.1 points."},{"id":"cggv:1cb52515-87ef-4ceb-90e1-2af42a343062_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:91e88ae1-f403-4cbe-913d-923e4f18783b","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"cggv:1cb52515-87ef-4ceb-90e1-2af42a343062_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:fa17fe28-2e41-4466-b202-061e3004bf18"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/27886618"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/27886618","rdfs:label":"ANKRD: p.Pro105Ser"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1,"dc:description":"No individual patient data and no clinical evidence provided, therefore, the score was reduced to 0.1."},{"id":"cggv:60a050d1-477d-4338-a16d-bd2b6c394d43_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:ab0c8311-2f5c-4e3a-9789-6b404f98391d","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"cggv:60a050d1-477d-4338-a16d-bd2b6c394d43_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:82ed81bd-7854-4f92-ad41-46e6e474b261","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014391.3(ANKRD1):c.197G>A (p.Arg66Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA136829"}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25163546"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25163546","rdfs:label":"ANKRD1: c.197G>A"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1,"dc:description":"No individual patient data, no segregation,no robust evidence for variant pathogenicity. Therefore, the default score of 0.5 is reduced to 0.1 points."},{"id":"cggv:d7a74f9c-e3fa-4271-bd2e-fe14516c12b4_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:b2d604fe-c190-43ce-9123-07ce3b50dd1b","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"cggv:d7a74f9c-e3fa-4271-bd2e-fe14516c12b4_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:2146a077-0f9e-42eb-b386-b17d6b2eec64","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014391.2(ANKRD1):c.28-1G>A (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377554252"}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25163546"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25163546","rdfs:label":"ANKRD1: c.28-1G>A"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1,"dc:description":"No individual patient data, no segregation,no robust evidence for variant pathogenicity. Therefore, the default score of 0.5 is reduced to 0.1 points."},{"id":"cggv:e287bebd-cc97-49fc-8150-bab5afc82e25_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:36b39ab1-52d4-4ca5-90cb-f52c38396084","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"cggv:e287bebd-cc97-49fc-8150-bab5afc82e25_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:fa17fe28-2e41-4466-b202-061e3004bf18"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19608030"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19608030","rdfs:label":"P105S (N2)"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1,"dc:description":"Pro105Ser mutations in ANKRD1 decrease its binding to talin-1, a gene that has been previously linked to DCM in experimental models. However, TLN1 (Talinn-1) is not an established, common DCM causal gene, therefore the evidence of functional alterations resulting from ANKRD1-p.Pro105Ser is not enough for a direct mechanistic link to DCM. Furthermore, the proband has not been screened for a broad panel of DCM genes. Therefore, the default score is reduced to 0.1."},{"id":"cggv:51f25628-aced-4a68-9e34-93d0bde536f9_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:b3e64ce1-8130-4e8f-a0c4-1fe453ad0dbd","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"cggv:51f25628-aced-4a68-9e34-93d0bde536f9_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:c3531fc9-cb2b-4b59-96a3-3ab1a49e66ee","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014391.2(ANKRD1):c.552G>A (p.Met184Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA211423267"}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19608030"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19608030","rdfs:label":"M184I"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1,"dc:description":"Met184Ile mutations in ANKRD1 decrease its binding to talin-1 and 4-and-a-half LIM domains 2 (FHL2). Talin-1 (TLN1) has been previously linked to DCM in experimental models (PMID: 28698364). However, TLN1 (Talinn-1) is not an established, common DCM causal gene, therefore the evidence of functional alterations resulting from ANKRD1-p.Met184Ile is not enough for a direct mechanistic link to DCM. Furthermore, the proband has not been screened for a broad panel of DCM genes. Therefore, the default score is reduced to 0.1."},{"id":"cggv:9de9a8a8-020a-4d26-9f74-9c7570a222d8_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:f5282a3a-92bd-4a05-aadd-bbf23f94a98d","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"MYH7 negative","sex":"Male","variant":{"id":"cggv:9de9a8a8-020a-4d26-9f74-9c7570a222d8_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:2163a1b4-700e-4279-81ab-5f2e78b5c462","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014391.3(ANKRD1):c.347C>T (p.Thr116Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5598747"}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525294"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525294","rdfs:label":"II.01"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1,"dc:description":"The patient was not screened for other gene variants. Therefore the score was reduced to 0.1."},{"id":"cggv:e6b762ad-ef63-46bb-b7ed-5dc9f20413d0_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:8415b65b-a152-4a03-ac31-bfa1fd3cb1f6","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"MYH7-negative","sex":"Male","variant":{"id":"cggv:e6b762ad-ef63-46bb-b7ed-5dc9f20413d0_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:82ed81bd-7854-4f92-ad41-46e6e474b261"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525294"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525294","rdfs:label":"G108-R66Q Proband: II.02"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1,"dc:description":"The patient was not screened for other gene variants. Therefore the score was reduced to 0.1."},{"id":"cggv:2ffb3799-6ecd-44e1-a7ce-25475ece656c_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:552884ba-0c0d-45f3-90b0-95836b339be5","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"cggv:2ffb3799-6ecd-44e1-a7ce-25475ece656c_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:7509130c-cd20-4044-802c-41d479add4c5"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25163546"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25163546","rdfs:label":"ANKRD1: 827C>T"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1,"dc:description":"No individual patient data, no segregation,no robust evidence for variant pathogenicity. Therefore, the default score of 0.5 is reduced to 0.1 points."},{"id":"cggv:7fdc18e8-0b91-4924-a4ee-3293764b1e03_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:c156cf6f-9d58-4df9-8c22-4ec713bb2b78","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"cggv:7fdc18e8-0b91-4924-a4ee-3293764b1e03_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:629fd3b4-332e-4147-96e4-b04105c81ee7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014391.3(ANKRD1):c.417C>A (p.Phe139Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA136841"}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/27886618"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/27886618","rdfs:label":"ANKRD: p.Phe139Leu"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1,"dc:description":"No individual patient data and no clinical evidence provided, therefore, the score was reduced to 0.1."},{"id":"cggv:0d0add1c-b730-4ffd-841f-4dbfa8a8ccc8_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:ee3979dd-15a4-4ce3-83df-6199b3c43134","type":"Proband","ageType":"cggv","ageUnit":"cggv","detectionMethod":"","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"cggv:0d0add1c-b730-4ffd-841f-4dbfa8a8ccc8_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:fa17fe28-2e41-4466-b202-061e3004bf18"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19608030"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19608030","rdfs:label":"P105S (N1)"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.1,"dc:description":"Pro105Ser mutations in ANKRD1 decrease its binding to talin-1, a gene that has been previously linked to DCM in experimental models. However, TLN1 (Talinn-1) is not an established, common DCM causal gene, therefore the evidence of functional alterations resulting from ANKRD1-p.Pro105Ser is not enough for a direct mechanistic link to DCM. Furthermore, the proband has not been screened for a broad panel of DCM genes. Therefore, the default score is reduced to 0.1."}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":1.7}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":1.7},{"id":"cggv:3dcc6918-d7e7-4385-b343-bc8b8678b3a4_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:3dcc6918-d7e7-4385-b343-bc8b8678b3a4_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:e9ad08cf-6384-4d57-a789-ed7b1d6bf78e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:b0be91c2-0c78-4311-a252-6c0a4fcb9877","type":"Finding","demonstrates":{"id":"cg:GeneExpressionB"},"dc:description":"Transforming growth factor (TGF)-beta1, CASQ2, EGR1, and TNNT1, TGF-beta1 and CASQ2 are up-regulated and EGR1 and TNNT1 are down-regulated in cells transduced with Val107Leu compared with wild-type ANKRD1 cDNA.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19608030","rdfs:label":"Gene expression change"}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0,"dc:description":"We do not consider this evidence supportive for DCM, since none of these affected genes has been clearly implicated in DCM. (no score assigned)"}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0},{"id":"cggv:3dcc6918-d7e7-4385-b343-bc8b8678b3a4_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:16230aff-87fa-4c05-9324-634fc07f7e1b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:d1fe6cc3-d282-42f2-a399-dd3d49936b0c","type":"FunctionalAlteration","dc:description":"Expression of the mutated CARP proteins showed less marked repressor activity than WT-CARP.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525294","rdfs:label":"Monitoring the CARP-responsive MLC2v promoter repression"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"cggv:7528c429-1cff-4aa5-ba9c-eadfecb6a95a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:0886bad6-85a7-465d-a289-648bbc9649de","type":"FunctionalAlteration","dc:description":"greater phenylephrine-induced hypertrophy","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525294","rdfs:label":"Measurment of the effects of CARP mutant on hypertrophy"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5,"dc:description":"We assign only 0.5 points to the collective evidence of functional alterations of 5 ANKRD1 variants (2 not shown because of lack of ClinVar or CA IDs), because the link to DCM is very weak."},{"id":"cggv:cd8eec99-093b-46f2-93a0-0c6ef4dda7e9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:88b3fa5c-8d98-414d-8832-209ef0941ac9","type":"FunctionalAlteration","dc:description":"The M184I mutation results in loss of CARP binding with Talin 1 and FHL2, and the P105S mutation in loss of Talin 1 binding. Intracellular localization of mutant CARP proteins is not altered. The mutation results in differential stretch-induced gene expression compared with wild-type CARP","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19608030","rdfs:label":"quantitative real-time reverse transcriptionâ€“PCR"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5,"dc:description":"Also the variant ANKRD1-Pro105Ser resulted in loss of CARP binding with Talin-1.\nBecause 0.5 points are the minimum score to be assigned for functional alterations, we assigned collectively 0.5 points for both Met184Ile & Pro105Ser."}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5}],"evidenceStrength":"Limited","sequence":1173,"specifiedBy":"GeneValidityCriteria7","strengthScore":3.2,"subject":{"id":"cggv:249263bd-1754-4dd5-9d53-5e7ea77512cf","type":"GeneValidityProposition","disease":"obo:MONDO_0005021","gene":"hgnc:15819","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","dc:description":"ANKRD1 was first reported in relation to autosomal dominant DCM in 2009 (Duboscq-Bidot L et al, 2009, PMID: 19525294). Human genetic evidence supporting this gene-disease relationship includes case level data and segregation data. At least 11 unique variants (missense (n=10) and nonsense (n=1)) have been reported in humans, representing at least 17 probands from 4 publications (Duboscq-Bidot L et al, 2009, PMID: 19525294; Moulik et al, 2009, PMID: 19608030, Dalin et al, 2017, PMID: 27886618, Haas et al, 2015, PMID: 25163546). Variants in this gene segregated with disease in 4 additional family members (Duboscq-Bidot L et al, 2009, PMID: 19525294). In addition, this gene-disease association is supported by evidence from expression studies (Duboscq-Bidot L et al, 2009, PMID: 19525294; Moulik et al, 2009, PMID: 19608030) and in vitro functional assays (Moulik et al, 2009, PMID: 19608030). In summary, there is limited evidence to support this gene-disease relationship. More evidence is needed to support the relationship of ANKRD1 with autosomal dominant DCM. This classification was approved by the ClinGen Dilated Cardiomyopathy Working Group on February 14, 2020 (SOP Version 7).\n","dc:isVersionOf":{"id":"cggv:3dcc6918-d7e7-4385-b343-bc8b8678b3a4"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}